224 related articles for article (PubMed ID: 35997090)
1. Carbidopa, an activator of aryl hydrocarbon receptor, suppresses IDO1 expression in pancreatic cancer and decreases tumor growth.
Korac K; Rajasekaran D; Sniegowski T; Schniers BK; Ibrahim AF; Bhutia YD
Biochem J; 2022 Sep; 479(17):1807-1824. PubMed ID: 35997090
[TBL] [Abstract][Full Text] [Related]
2. Carbidopa is an activator of aryl hydrocarbon receptor with potential for cancer therapy.
Ogura J; Miyauchi S; Shimono K; Yang S; Gonchigar S; Ganapathy V; Bhutia YD
Biochem J; 2017 Sep; 474(20):3391-3402. PubMed ID: 28963435
[TBL] [Abstract][Full Text] [Related]
3. Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan-Kynurenine-Aryl Hydrocarbon Axis.
Labadie BW; Bao R; Luke JJ
Clin Cancer Res; 2019 Mar; 25(5):1462-1471. PubMed ID: 30377198
[TBL] [Abstract][Full Text] [Related]
4. Indoleamine 2, 3-Dioxygenase 1 Mediates Survival Signals in Chronic Lymphocytic Leukemia
Atene CG; Fiorcari S; Mesini N; Alboni S; Martinelli S; Maccaferri M; Leonardi G; Potenza L; Luppi M; Maffei R; Marasca R
Front Immunol; 2022; 13():832263. PubMed ID: 35371054
[TBL] [Abstract][Full Text] [Related]
5. Interferon-γ induces a tryptophan-selective amino acid transporter in human colonic epithelial cells and mouse dendritic cells.
Bhutia YD; Babu E; Ganapathy V
Biochim Biophys Acta; 2015 Feb; 1848(2):453-62. PubMed ID: 25450809
[TBL] [Abstract][Full Text] [Related]
6. Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes.
Solvay M; Holfelder P; Klaessens S; Pilotte L; Stroobant V; Lamy J; Naulaerts S; Spillier Q; Frédérick R; De Plaen E; Sers C; Opitz CA; Van den Eynde BJ; Zhu J
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37344101
[TBL] [Abstract][Full Text] [Related]
7. Indoleamine 2,3-dioxygenase (IDO1) - Can dendritic cells and monocytes expressing this moonlight enzyme change the phase of Parkinson's Disease?
Gonçalves M; Rodrigues-Santos P; Januário C; Cosentino M; Pereira FC
Int Immunopharmacol; 2024 May; 133():112062. PubMed ID: 38652967
[TBL] [Abstract][Full Text] [Related]
8. Targeting the IDO1/TDO2-KYN-AhR Pathway for Cancer Immunotherapy - Challenges and Opportunities.
Cheong JE; Sun L
Trends Pharmacol Sci; 2018 Mar; 39(3):307-325. PubMed ID: 29254698
[TBL] [Abstract][Full Text] [Related]
9. 1-Methyl-D-tryptophan activates aryl hydrocarbon receptor, a pathway associated with bladder cancer progression.
Matheus LHG; Dalmazzo SV; Brito RBO; Pereira LA; de Almeida RJ; Camacho CP; Dellê H
BMC Cancer; 2020 Sep; 20(1):869. PubMed ID: 32907554
[TBL] [Abstract][Full Text] [Related]
10. IDO1/TDO dual inhibitor RY103 targets Kyn-AhR pathway and exhibits preclinical efficacy on pancreatic cancer.
Liang H; Li T; Fang X; Xing Z; Zhang S; Shi L; Li W; Guo L; Kuang C; Liu H; Yang Q
Cancer Lett; 2021 Dec; 522():32-43. PubMed ID: 34520819
[TBL] [Abstract][Full Text] [Related]
11. NO
Wang L; Tang W; Yang S; He P; Wang J; Gaedcke J; Ströbel P; Azizian A; Ried T; Gaida MM; Yfantis HG; Lee DH; Lal A; Van den Eynde BJ; Alexander HR; Ghadimi BM; Hanna N; Hussain SP
Int J Cancer; 2020 Jun; 146(11):3160-3169. PubMed ID: 31609478
[TBL] [Abstract][Full Text] [Related]
12. Indoleamine 2,3-Dioxygenase 1 Deletion-Mediated Kynurenine Insufficiency in Vascular Smooth Muscle Cells Exacerbates Arterial Calcification.
Ouyang L; Yu C; Xie Z; Su X; Xu Z; Song P; Li J; Huang H; Ding Y; Zou MH
Circulation; 2022 Jun; 145(24):1784-1798. PubMed ID: 35582948
[TBL] [Abstract][Full Text] [Related]
13. USP14 promotes tryptophan metabolism and immune suppression by stabilizing IDO1 in colorectal cancer.
Shi D; Wu X; Jian Y; Wang J; Huang C; Mo S; Li Y; Li F; Zhang C; Zhang D; Zhang H; Huang H; Chen X; Wang YA; Lin C; Liu G; Song L; Liao W
Nat Commun; 2022 Sep; 13(1):5644. PubMed ID: 36163134
[TBL] [Abstract][Full Text] [Related]
14. Epithelial Indoleamine 2,3-Dioxygenase 1 Modulates Aryl Hydrocarbon Receptor and Notch Signaling to Increase Differentiation of Secretory Cells and Alter Mucus-Associated Microbiota.
Alvarado DM; Chen B; Iticovici M; Thaker AI; Dai N; VanDussen KL; Shaikh N; Lim CK; Guillemin GJ; Tarr PI; Ciorba MA
Gastroenterology; 2019 Oct; 157(4):1093-1108.e11. PubMed ID: 31325428
[TBL] [Abstract][Full Text] [Related]
15. Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors activate the aryl hydrocarbon receptor.
Moyer BJ; Rojas IY; Murray IA; Lee S; Hazlett HF; Perdew GH; Tomlinson CR
Toxicol Appl Pharmacol; 2017 May; 323():74-80. PubMed ID: 28336214
[TBL] [Abstract][Full Text] [Related]
16. Expression of the IDO1/TDO2-AhR pathway in tumor cells or the tumor microenvironment is associated with Merkel cell polyomavirus status and prognosis in Merkel cell carcinoma.
Wardhani LO; Matsushita M; Iwasaki T; Kuwamoto S; Nonaka D; Nagata K; Kato M; Kitamura Y; Hayashi K
Hum Pathol; 2019 Feb; 84():52-61. PubMed ID: 30240768
[TBL] [Abstract][Full Text] [Related]
17. Kynurenine promotes neonatal heart regeneration by stimulating cardiomyocyte proliferation and cardiac angiogenesis.
Zhang D; Ning J; Ramprasath T; Yu C; Zheng X; Song P; Xie Z; Zou MH
Nat Commun; 2022 Oct; 13(1):6371. PubMed ID: 36289221
[TBL] [Abstract][Full Text] [Related]
18. Targeting Indoleamine 2,3-Dioxygenase 1: Fighting Cancers
Yang C; Ng CT; Li D; Zhang L
Front Immunol; 2021; 12():725204. PubMed ID: 34539663
[TBL] [Abstract][Full Text] [Related]
19. Tryptophan: A Rheostat of Cancer Immune Escape Mediated by Immunosuppressive Enzymes IDO1 and TDO.
Kim M; Tomek P
Front Immunol; 2021; 12():636081. PubMed ID: 33708223
[TBL] [Abstract][Full Text] [Related]
20. Immune-regulated IDO1-dependent tryptophan metabolism is source of one-carbon units for pancreatic cancer and stellate cells.
Newman AC; Falcone M; Huerta Uribe A; Zhang T; Athineos D; Pietzke M; Vazquez A; Blyth K; Maddocks ODK
Mol Cell; 2021 Jun; 81(11):2290-2302.e7. PubMed ID: 33831358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]